Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kenji Yachiku"'
Autor:
Ryoma Okawa, Koushirou Sogawa, Motoko Shiozaki, Kenji Yachiku, Takanori Miura, Takashi Shibata, Sachiko Ezoe
Publikováno v:
Regenerative Therapy, Vol 21, Iss , Pp 250-257 (2022)
Background: Recently, various regenerative therapies have been developed based on induced pluripotent stem (iPS) cells. However, hygienic control strategies have not been established at the manufacturing facilities. We aimed to evaluate the safety an
Externí odkaz:
https://doaj.org/article/c0f82c69d9e547febceb56d7717f88fd
Autor:
Koushirou Sogawa, Ryoma Okawa, Kenji Yachiku, Motoko Shiozaki, Takanori Miura, Hiroshi Takayanagi, Takashi Shibata, Sachiko Ezoe
Publikováno v:
Regenerative Therapy, Vol 14, Iss , Pp 184-190 (2020)
Introduction: Hygienic management is more important in the manufacturing of cell products than in the production of chemical agents, because cell material and final product cannot be decontaminated. On the other hand, especially in the selection of h
Externí odkaz:
https://doaj.org/article/a888a9035d3549a3ac6ea2a53cb05223
Autor:
Masakazu Aihara, Tomoko Irie, Keiko Yasukawa, Itsushi Minoura, Noriko Miyauchi, Mitsumi Nishi, Norikazu Katayama, Kenji Yachiku, Hideaki Jinnouchi, Takashi Kadowaki, Toshimasa Yamauchi, Yutaka Yatomi, Naoto Kubota, Koshin Sekimizu
Publikováno v:
Clinica Chimica Acta. 542:117272
Autor:
Takashi Shibata, Ryoma Okawa, Motoko Shiozaki, Hiroshi Takayanagi, Takanori Miura, Kenji Yachiku, Koushirou Sogawa, Sachiko Ezoe
Publikováno v:
Regenerative Therapy, Vol 14, Iss, Pp 184-190 (2020)
Introduction Hygienic management is more important in the manufacturing of cell products than in the production of chemical agents, because cell material and final product cannot be decontaminated. On the other hand, especially in the selection of hy
Autor:
Koushirou, Sogawa, Ryoma, Okawa, Kenji, Yachiku, Motoko, Shiozaki, Takanori, Miura, Hiroshi, Takayanagi, Takashi, Shibata, Sachiko, Ezoe
Publikováno v:
Regenerative Therapy
Introduction Hygienic management is more important in the manufacturing of cell products than in the production of chemical agents, because cell material and final product cannot be decontaminated. On the other hand, especially in the selection of hy
Autor:
Tomoko Kobayashi, Kenya Nasu, Tohru Kobayashi, Nobuhisa Awata, Kenji Yachiku, Yoshihiro Takeda, Etsuo Tsuchikane
Publikováno v:
The American Journal of Cardiology. 93:339-343
To evaluate the influence of preintervention remodeling on subsequent vessel behavior after directional coronary atherectomy (DCA) under intravascular ultrasound (IVUS) guidance, serial (before and after DCA and at 6-month follow-up) IVUS data were a
Autor:
Yoshihiro Takeda, Etsuo Tsuchikane, Yoshiki Kobayashi, Kenji Yachiku, Kenya Nasu, Tohru Kobayashi, Nobuhisa Awata, Hiroaki Matsumoto
Publikováno v:
Circulation Journal. 67:763-767
Percutaneous transluminal septal myocardial ablation (PTSMA) is a new therapeutic option for patients with hypertrophic obstructive cardiomyopathy (HOCM). In the present study, the acute and follow-up results of PTSMA were evaluated. From August 1997
Autor:
Jinnouchi, Hideaki1 (AUTHOR), Yoshida, Akira1 (AUTHOR), Taniguchi, Mariko1 (AUTHOR), Yamauchi, Eisaku2 (AUTHOR), Kurosawa, Daisuke3 (AUTHOR), Yachiku, Kenji3 (AUTHOR), Minoura, Itsushi3 (AUTHOR), Kadowaki, Takashi4,5 (AUTHOR), Yamauchi, Toshimasa4 (AUTHOR), Aihara, Masakazu4 (AUTHOR), Kubota, Naoto4,6 (AUTHOR), Sekimizu, Koshin3 (AUTHOR) sekimizu@provigate.com
Publikováno v:
Diabetes Therapy. Jul2024, Vol. 15 Issue 7, p1561-1575. 15p.
Autor:
Etsuo, Tsuchikane, Yoshihiro, Takeda, Tohru, Kobayashi, Kenji, Yachiku, Kenya, Nasu, Yoshiki, Kobayashi, Hiroaki, Matsumoto, Nobuhisa, Awata
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 67(9)
Percutaneous transluminal septal myocardial ablation (PTSMA) is a new therapeutic option for patients with hypertrophic obstructive cardiomyopathy (HOCM). In the present study, the acute and follow-up results of PTSMA were evaluated. From August 1997
Autor:
Tsutomu Nakagawa, Motohiro Kirino, Kenji Yachiku, Hisatoyo Hiraoka, Yoshihiro Takeda, Johan H. C. Reiber, Shinichi Sato, Nobuhiko Shibata, Nobuhisa Awata, Osamu Kato, Hiromu Nakajima, Tomoko Kobayashi, Tohru Kobayashi, Tadao Itoh, Yumiko Toyama, Minoru Iida
Publikováno v:
International journal of cardiology. 97(1)
The potential benefit of cholesterol-lowering therapy for normocholesterolemic patients with coronary artery disease (CAD) has not been clarified. The Prevention of Coronary Sclerosis (PCS) Study was designed to evaluate the effect of pravastatin on